HANNAH CLARK: Open Payments
NPI 1245614726 · HOLLAND, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,784 in 6 payments from 5 companies in 2025. Trend: 2023 $534 · 2024 $720 · 2025 $2,784
Consulting: $2,250Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma Global Development | 1 | $2,250 |
| Astellas Pharma US Inc | 2 | $152 |
| Alexion Pharmaceuticals, Inc. | 1 | $135 |
| E.R. Squibb & Sons, L.L.C. | 1 | $128 |
| Regeneron Healthcare Solutions, Inc. | 1 | $120 |
Products named: Veozah, ULTOMIRIS, REBLOZYL, EYLEA HD.
Industry payments across MI — which companies pay providers there.
